Announcements Trials
Browse Landscape

Phase

Phase NA 58Phase 2 36Phase 1 28Phase 3 16Phase 1/2 10Phase 4 9Phase EARLY_PHASE1 7Phase 2/3 5

Status

Unknown 2Withdrawn 1Terminated 1Completed 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Sarcoma 5Thoracic 1Genitourinary 1

Conditions

Sarcoma 10Osteosarcoma 5Bone Neoplasms 5Neurofibrosarcoma 3Neoplasms 3Lung Neoplasms 3Liposarcoma 3Leiomyosarcoma 3Sarcoma, Synovial 2Sarcoma, Ewing 2Sarcoma, Alveolar Soft Part 2Nerve Sheath Neoplasms 2Neoplasm Metastasis 2Lymphoma 2Histiocytoma, Malignant Fibrous 2Gliosarcoma 2Gastrointestinal Stromal Tumors 2Fibrosarcoma 2Chondrosarcoma, Extraskeletal Myxoid 2Breast Neoplasms 2Waldenstrom Macroglobulinemia 1Urogenital Neoplasms 1Thrombocythemia, Essential 1Stomach Neoplasms 1Sezary Syndrome 1Sarcoma, Clear Cell 1Prostatic Neoplasms 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Methotrexate 1Grafton demineralized bone matrix gel 1Exercise Therapy 1Etanercept 1Doxorubicin 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2/3 × Bone Neoplasms × Sarcoma × Clear all
NCT04963517 2024-12-06

proGAIT

Universität Duisburg-Essen

Phase 2/3 Completed
11 enrolled
Sarcoma

Bone Neoplasms, Motor Activity

NCT05057130 2024-04-01

Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors

Blokhin's Russian Cancer Research Center

Phase 2/3 Unknown
50 enrolled
Sarcoma

Bone Neoplasms, Neoplasms, Connective Tissue, Sarcoma, Osteosarcoma, Neoplasms, Connective and Soft Tissue

NCT02302651 2014-11-27

Non-invasive Focal Therapy for Osteoid Osteoma

University of Roma La Sapienza

Phase 2/3 Unknown
60 enrolled
Sarcoma

Bone Neoplasms, Osteoma, Osteoid

NCT00851162 2012-11-28

Using Mesenchymal Stem Cells to Fill Bone Void Defects in Patients With Benign Bone Lesions

Emory University

Phase 2/3 Withdrawn
Sarcoma

Bone Neoplasms

NCT00127387 2012-06-26

Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia

The University of Texas Health Science Center at San Antonio

Phase 2/3 Terminated
54 enrolled
GenitourinarySarcomaThoracic

Bone Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡